Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P G Pappas

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
International Journal of STD & AIDS|November 19, 2011
Predictors of poor clinical outcome of cryptococcal meningitis in HIV-infected patientsT Anekthananon, W Manosuthi, P Chetchotisakd, et al.
Developments in Biologicals|January 5, 2002
Viral latency--the papillomavirus modelT R Broker, G Jin, A Croom-Rivers, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 2, 2008
Pulmonary cryptococcosis in patients without HIV infection: factors associated with disseminated diseaseJ W Baddley, J R Perfect, R A Oster, et al.
Journal of Clinical Microbiology|April 1, 1996
Molecular subtype distribution of Cryptococcus neoformans in four areas of the United States. Cryptococcal Disease Active Surveillance GroupM E Brandt, L C Hutwagner, L A Klug, et al.
The New England Journal of Medicine|November 17, 1994
A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National InstituteJ H Rex, J E Bennett, A M Sugar, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 11, 2018
Epidemiology and outcomes of Clostridium difficile infection in allogeneic hematopoietic cell and lung transplant recipientsE R Dubberke, K A Reske, M A Olsen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 10, 2017
Management of an Outbreak of Exophiala dermatitidis Bloodstream Infections at an Outpatient Oncology ClinicAmber Vasquez, D Zavasky, N A Chow, et al.
The Journal of Infectious Diseases|January 7, 1999
Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance GroupR A Hajjeh, L A Conn, D S Stephens, et al.
Lancet (London, England)|October 26, 2005
Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trialB J Kullberg, J D Sobel, M Ruhnke, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 31, 2001
Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapyP G Pappas, J R Perfect, G A Cloud, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
International Journal of STD & AIDS|November 19, 2011
Predictors of poor clinical outcome of cryptococcal meningitis in HIV-infected patientsT Anekthananon, W Manosuthi, P Chetchotisakd, et al.
Developments in Biologicals|January 5, 2002
Viral latency--the papillomavirus modelT R Broker, G Jin, A Croom-Rivers, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 2, 2008
Pulmonary cryptococcosis in patients without HIV infection: factors associated with disseminated diseaseJ W Baddley, J R Perfect, R A Oster, et al.
Journal of Clinical Microbiology|April 1, 1996
Molecular subtype distribution of Cryptococcus neoformans in four areas of the United States. Cryptococcal Disease Active Surveillance GroupM E Brandt, L C Hutwagner, L A Klug, et al.
The New England Journal of Medicine|November 17, 1994
A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National InstituteJ H Rex, J E Bennett, A M Sugar, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 11, 2018
Epidemiology and outcomes of Clostridium difficile infection in allogeneic hematopoietic cell and lung transplant recipientsE R Dubberke, K A Reske, M A Olsen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 10, 2017
Management of an Outbreak of Exophiala dermatitidis Bloodstream Infections at an Outpatient Oncology ClinicAmber Vasquez, D Zavasky, N A Chow, et al.
The Journal of Infectious Diseases|January 7, 1999
Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance GroupR A Hajjeh, L A Conn, D S Stephens, et al.
Lancet (London, England)|October 26, 2005
Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trialB J Kullberg, J D Sobel, M Ruhnke, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 31, 2001
Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapyP G Pappas, J R Perfect, G A Cloud, et al.
Pageof 7